J&J’s Tremfya shows fistula remission in Crohn’s subgroups

ImmuCell reports 46% Q3 sales increase to $8.0 million

Investing.com · News 8m ago

Northern Oil and Gas reports Q3 operations, share buybacks

Investing.com · News 9m ago

International Paper declares quarterly dividend of $0.4625

Investing.com · News 9m ago

Oncolytics receives cancer immunotherapy patent in multiple countries

Investing.com · News 9m ago

Organogenesis announces publication of diabetic foot ulcer trial

Investing.com · News 9m ago

Oil Climbs as Fighting Flares in Middle East, Ukraine

Dow Jones · Markets 10m ago

J&J reports three-year tremfya data for Crohn’s disease

Investing.com · News 16m ago

Myomo appoints Mary-Katherine McClure as chief commercial officer

Investing.com · News 16m ago

ArriVent doses first patient in ARR-002 ovarian cancer trial

Investing.com · News 16m ago

BBH Capital Partners exits Granite Group via Watsco deal

Investing.com · News 16m ago